XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Common Stock
Deficit
Accumulated Other Comprehensive Income (Loss)
Total Shareholders' Equity
Non-Controlling Interests
Beginning balance ( in shares) at Dec. 31, 2021   156,262,199        
Beginning balance at Dec. 31, 2021 $ 295,526 $ 685,903 $ (396,271) $ 1,943 $ 291,575 $ 3,951
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (14,730)   (14,729)   (14,729) (1)
Other comprehensive loss 1,766     1,766 1,766  
Shares Issued For Cash By At The Market Offering Shares   413,751        
Shares issued for cash by at-the-market offering 4,260 $ 4,260     4,260  
Share issuance cost 96 96     96  
Share-based compensation 862 $ 862     862  
shares issued for exrcise of stock options (in shares)   135,926        
Shares issued for exercise of stock options (328) $ (328)     (328)  
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units 884 $ 884     884  
Shares issued for consulting services (in shares)   6,022        
Shares issued for consulting services $ 51 $ 51     51  
Shares issued for exercise of stock appreciation rights (in shares) 362,350          
Ending balance (in shares) at Mar. 31, 2022   157,180,248        
Ending balance at Mar. 31, 2022 $ 287,083 $ 690,424 (411,000) 3,709 283,133 3,950
Beginning balance ( in shares) at Dec. 31, 2021   156,262,199        
Beginning balance at Dec. 31, 2021 295,526 $ 685,903 (396,271) 1,943 291,575 3,951
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (42,043)          
Other comprehensive loss (4,524)          
Ending balance (in shares) at Sep. 30, 2022   157,607,156        
Ending balance at Sep. 30, 2022 259,864 $ 696,808 (438,221) (2,581) 256,006 3,858
Beginning balance ( in shares) at Mar. 31, 2022   157,180,248        
Beginning balance at Mar. 31, 2022 287,083 $ 690,424 (411,000) 3,709 283,133 3,950
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (18,059)   (18,054)   (18,054) (5)
Other comprehensive loss (3,488)     (3,488) (3,488)  
Shares Issued For Cash By At The Market Offering Shares   356,028        
Shares issued for cash by at-the-market offering 3,808 $ 3,808     3,808  
Share issuance cost 86 86     86  
Share-based compensation 1,147 $ 1,147     1,147  
shares issued for exrcise of stock options (in shares)   24,326        
Shares issued for exercise of stock options (67) $ (67)     (67)  
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units 11 $ 11     11  
Shares issued for consulting services (in shares)   5,183        
Shares issued for consulting services 55 $ 55     55  
Shares issued for exercise of stock appreciation rights (in shares)   3,635        
Ending balance (in shares) at Jun. 30, 2022   157,569,420        
Ending balance at Jun. 30, 2022 270,516 $ 695,404 (429,054) 221 266,571 3,945
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (9,254)   (9,167)     (87)
Other comprehensive loss (2,802)     (2,802) (2,802)  
Share-based compensation 1,283 $ 1,283     1,283  
shares issued for exrcise of stock options (in shares)   28,781        
Shares issued for exercise of stock options (77) $ (77)     (77)  
Shares issued for consulting services (in shares)   8,955        
Shares issued for consulting services 44 $ 44     44  
Ending balance (in shares) at Sep. 30, 2022   157,607,156        
Ending balance at Sep. 30, 2022 259,864 $ 696,808 (438,221) (2,581) 256,006 3,858
Beginning balance ( in shares) at Dec. 31, 2022   157,682,531        
Beginning balance at Dec. 31, 2022 244,409 $ 698,493 (456,120) (1,946) 240,427 3,982
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 114,264   114,265   114,265 (1)
Share-based compensation 1,186 $ 1,186     1,186  
shares issued for exrcise of stock options (in shares)   34,219        
Shares issued for exercise of stock options (72) $ (72)     (72)  
Shares issued for the vesting of restricted stock units (in shares)   312,662        
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units 918 $ 918     918  
Ending balance (in shares) at Mar. 31, 2023   158,029,412        
Ending balance at Mar. 31, 2023 359,013 $ 698,833 (341,855) (1,946) 355,032 3,981
Beginning balance ( in shares) at Dec. 31, 2022   157,682,531        
Beginning balance at Dec. 31, 2022 244,409 $ 698,493 (456,120) (1,946) 240,427 3,982
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 119,849          
Other comprehensive loss 0          
Ending balance (in shares) at Sep. 30, 2023   160,463,370        
Ending balance at Sep. 30, 2023 383,328 $ 717,564 (336,153) (1,946) 379,465 3,863
Beginning balance ( in shares) at Mar. 31, 2023   158,029,412        
Beginning balance at Mar. 31, 2023 359,013 $ 698,833 (341,855) (1,946) 355,032 3,981
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (4,885)   (4,861)   (4,861) (24)
Share-based compensation 1,554 $ 1,554     1,554  
shares issued for exrcise of stock options (in shares)   45,126        
Shares issued for exercise of stock options (312) $ (312)     (312)  
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units $ 848 $ 848     848  
Shares issued for exercise of stock appreciation rights (in shares) 164,258          
Ending balance (in shares) at Jun. 30, 2023   158,238,796        
Ending balance at Jun. 30, 2023 $ 355,146 $ 699,851 (346,716) (1,946) 351,189 3,957
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 10,469   10,563   10,563 (94)
Other comprehensive loss 0          
Shares Issued For Cash By At The Market Offering Shares   2,048,172        
Shares issued for cash by at-the-market offering 16,416 $ 16,416     16,416  
Share issuance cost 369 369     369  
Share-based compensation 1,293 $ 1,293     1,293  
shares issued for exrcise of stock options (in shares)   100,522        
Shares issued for exercise of stock options (247) $ (247)     (247)  
Shares issued for consulting services (in shares)   70,336        
Shares issued for consulting services (126) $ (126)     (126)  
Shares issued for exercise of stock appreciation rights (in shares)   5,544        
Ending balance (in shares) at Sep. 30, 2023   160,463,370        
Ending balance at Sep. 30, 2023 $ 383,328 $ 717,564 $ (336,153) $ (1,946) $ 379,465 $ 3,863